Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Nacuity Pharmaceuticals, Inc. See All Filings	D	2025-12-29 17:50:00 UTC
Amount To Be Raised $30,000,000 Associated Brokers / Dealers Maxim Group LLC CIK Number 0001690279 Filed Document 0001690279-25-000002 Exclusions or Exemptions 506b Accepted Date 2025-12-29 17:50:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Nacuity Pharmaceuticals, Inc. See All Filings	D/A	2022-01-03 16:28:34 UTC
Amount To Be Raised $17,400,000 Associated Brokers / Dealers Maxim Group LLC CIK Number 0001690279 Filed Document 0001690279-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-01-03 16:28:34 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Nacuity Pharmaceuticals, Inc. See All Filings	D	2021-03-30 13:33:03 UTC
Amount To Be Raised $11,000,000 Associated Brokers / Dealers Maxim Group LLC CIK Number 0001690279 Filed Document 0001690279-21-000003 Exclusions or Exemptions 506b Accepted Date 2021-03-30 13:33:03 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Nacuity Pharmaceuticals, Inc. See All Filings	D/A	2017-07-20 16:17:38 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers Maxim Group LLC CIK Number 0001690279 Filed Document 0001250853-17-000065 Exclusions or Exemptions 506b Accepted Date 2017-07-20 16:17:38 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Nacuity Pharmaceuticals, Inc. See All Filings	D	2017-06-27 15:04:43 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers Maxim Group LLC CIK Number 0001690279 Filed Document 0001250853-17-000059 Exclusions or Exemptions 506b Accepted Date 2017-06-27 15:04:43 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Nacuity Pharmaceuticals, Inc. See All Filings	D	2016-12-08 17:15:38 UTC
Amount To Be Raised $2,500,000 Associated Brokers / Dealers N/A CIK Number 0001690279 Filed Document 0001250853-16-000186 Exclusions or Exemptions 506b Accepted Date 2016-12-08 17:15:38 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity